Valentini, Viola
 Distribuzione geografica
Continente #
EU - Europa 713
NA - Nord America 578
AS - Asia 162
AF - Africa 2
Totale 1.455
Nazione #
US - Stati Uniti d'America 576
DE - Germania 336
SE - Svezia 114
CN - Cina 104
UA - Ucraina 90
RU - Federazione Russa 37
FR - Francia 31
GB - Regno Unito 27
IE - Irlanda 23
IT - Italia 22
IN - India 21
SG - Singapore 17
FI - Finlandia 15
TR - Turchia 14
AT - Austria 4
ES - Italia 3
NL - Olanda 3
BE - Belgio 2
CA - Canada 2
CI - Costa d'Avorio 2
CZ - Repubblica Ceca 2
ID - Indonesia 2
KR - Corea 2
CH - Svizzera 1
GR - Grecia 1
MK - Macedonia 1
OM - Oman 1
PT - Portogallo 1
TW - Taiwan 1
Totale 1.455
Città #
Chandler 141
Jacksonville 53
Ashburn 34
San Mateo 30
Nürnberg 29
Nanjing 27
Dublin 23
Dearborn 22
Ann Arbor 20
Wilmington 18
Woodbridge 16
Boston 14
Izmir 13
Singapore 11
Houston 10
Lawrence 10
Moscow 10
Redwood City 10
Marseille 9
Milan 9
Shenyang 9
Lancaster 8
New York 8
Saint Petersburg 8
Zhengzhou 8
Chicago 7
Hebei 7
Los Angeles 7
Nanchang 7
Kunming 6
University Park 6
Boardman 5
Munich 5
Princeton 5
Simi Valley 5
Bremen 4
Fairfield 4
Hefei 4
Jiaxing 4
Seattle 4
Vienna 4
Detroit 3
Hangzhou 3
Mountain View 3
Abidjan 2
Brno 2
Brussels 2
Cambridge 2
Cattolica 2
Changsha 2
Guangzhou 2
Jinan 2
Lanzhou 2
Leawood 2
Monmouth Junction 2
Ningbo 2
Ottawa 2
Redmond 2
Seoul 2
Shanghai 2
Tianjin 2
Washington 2
Banyuwangi 1
Barcelona 1
Bolzano 1
Busto Arsizio 1
Changchun 1
Chengdu 1
Columbus 1
Cosenza 1
Costa Mesa 1
Edinburgh 1
Frankfurt am Main 1
Fuzhou 1
Groningen 1
Gunzenhausen 1
Gurgaon 1
Hyderabad 1
Indiana 1
Jakarta 1
Kocaeli 1
Kolkata 1
Libertyville 1
Mcallen 1
Miami 1
Mumbai 1
Paravola 1
Philadelphia 1
Phoenix 1
Prilep 1
Pune 1
Sacramento 1
San Diego 1
San Francisco 1
San Jose 1
Taizhou 1
Trumbull 1
Utrecht 1
Zurich 1
Totale 716
Nome #
Subcutaneous abscess as a side-effect of cetuximab therapy 153
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 125
Oncologic outcomes in advanced laryngeal squamous cell carcinomas treated with different modalities in a single institution: a retrospective analysis of 65 cases 115
Radiotherapy and concomitant temozolomide during the first and last weeks in high grade gliomas: long-term analysis of a phase II study 110
Subcutaneous abscess as a side-effect of cetuximab therapy 109
Can "early" and "late"18F-FDG PET-CT be used as prognostic factors for the clinical outcome of patients with locally advanced head and neck cancer treated with radio-chemotherapy? 106
Comparison of total laryngectomy with surgical (cricohyoidopexy) and nonsurgical organ-preservation modalities in advanced laryngeal squamous cell carcinomas: A multicenter retrospective analysis 103
Recurrence in region of spared parotid gland in patient receiving definitive intensity-modulated radiotherapy for nasopharyngeal cancer: A case report 99
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1) 98
Chemoradiation therapy and IORT in locally advanced rectal cancer: preliminary results in 36 patients 96
Locally recurrent rectal cancer: prognostic factors and long-term outcomes of multimodal therapy 90
Intraoperative radiation therapy in integrated treatment of rectal cancers. Results of phase II study 73
Endoscopic horizontal partial laryngectomy by CO(2) laser in the management of supraglottic squamous cell carcinoma 71
Whole liver intraoperative irradiation after partial hepatectomy produces minimal functional and pathologic lesions 63
Forward planned intensity modulated radiotherapy (IMRT) for whole breast postoperative radiotherapy. Is it useful? When? 60
Totale 1.471
Categoria #
all - tutte 4.680
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.680


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020257 47 14 18 16 23 28 29 3 13 26 25 15
2020/2021141 3 17 0 20 18 11 17 2 19 2 25 7
2021/2022147 16 15 2 10 14 6 1 19 12 5 17 30
2022/2023346 39 53 22 49 30 40 18 36 38 6 11 4
2023/2024126 9 38 3 5 9 9 5 15 2 4 13 14
2024/20259 9 0 0 0 0 0 0 0 0 0 0 0
Totale 1.471